Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma
โ Scribed by Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Hiroyuki Yoshikawa
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 188 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND: Mucinous and clear cell histology have been associated with adverse prognosis in ovarian carcinomas. The authors compared the outcome of these subtypes with that of serous tumors in patients who were treated with combination paclitaxel/platinum at their center. ## METHO
## BACKGROUND. The aim of the current study was to evaluate the in vitro effect of IL-12 on the natural cytotoxicity of peripheral blood mononuclear cells (PBMCs) obtained from patients who underwent adjuvant-based cisplatin polychemotherapy for advanced ovarian carcinoma. The authors also investi